Development of a Sustainable Release System for a Ranibizumab Biosimilar Using Poly(lactic-co-glycolic acid) Biodegradable Polymer-Based Microparticles as a Platform von Tanetsugu, Yusuke, Tagami, Tatsuaki, Terukina, Takayuki, Ogawa, Takaya, Ohta, Masato, Ozeki, Tetsuya

Volltext

Phase 2 study of bosutinib in Japanese patients with newly diagnosed chronic phase chronic myeloid leukemia von Hino, Masayuki, Matsumura, Itaru, Fujisawa, Shin, Ishizawa, Kenichi, Ono, Takaaki, Sakaida, Emiko, Sekiguchi, Naohiro, Tanetsugu, Yusuke, Fukuhara, Kei, Ohkura, Masayuki, Koide, Yuichiro, Takahashi, Naoto

Volltext

Bosutinib in Japanese patients with newly diagnosed chronic-phase chronic myeloid leukemia: final 3-year follow-up results of a phase 2 study von Ono, Takaaki, Hino, Masayuki, Matsumura, Itaru, Fujisawa, Shin, Ishizawa, Kenichi, Sakaida, Emiko, Sekiguchi, Naohiro, Ono, Chiho, Aizawa, Mana, Tanetsugu, Yusuke, Koide, Yuichiro, Takahashi, Naoto

Volltext

Safety profile of bosutinib in Japanese versus non-Japanese patients with chronic myeloid leukemia: a pooled analysis von Takahashi, Naoto, Cortes, Jorge E., Sakaida, Emiko, Ishizawa, Kenichi, Ono, Takaaki, Doki, Noriko, Matsumura, Itaru, García-Gutiérrez, Valentín, Rosti, Gianantonio, Ono, Chiho, Ohkura, Masayuki, Tanetsugu, Yusuke, Viqueira, Andrea, Brümmendorf, Tim H.

Volltext

Phase 2 Study of Bosutinib in Japanese Patients with Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia von Takahashi, Naoto, Matsumura, Itaru, Fujisawa, Shin, Ishizawa, Kenichi, ONO, Takaaki, Sakaida, Emiko, Sekiguchi, Naohiro, Tanetsugu, Yusuke, Fukuhara, Kei, Ohkura, Masayuki, Koide, Yuichiro, Hino, Masayuki

Volltext

抗悪性腫瘍薬および各疾患領域治療薬の日米における直近5年間の初回承認用法・用量の比較調査：国際共同開発における抗悪性腫瘍薬の早期開発戦略の考察... von 木村, 信之, 舩造, 正英, 種継, 友祐, 長澤, 崇

Volltext